Can Hydroxyzine Help with Nightmares?
Yes, hydroxyzine can help reduce nightmares, particularly in patients with PTSD-associated nightmares, though it is less effective than prazosin and should be considered a second-line option. 1
Evidence Quality and Positioning
The American Academy of Sleep Medicine guidelines do not specifically recommend hydroxyzine as a first-line treatment for nightmare disorder, focusing instead on prazosin for PTSD-associated nightmares and cognitive-behavioral therapies. 2, 3 However, research evidence demonstrates that hydroxyzine has meaningful efficacy for nightmare reduction.
Clinical Efficacy Data
The strongest evidence comes from a 2014 randomized controlled trial comparing hydroxyzine directly to prazosin in 100 PTSD patients over 8 weeks. 1 Key findings include:
- Both hydroxyzine and prazosin significantly improved sleep quality and reduced nightmares compared to placebo 1
- Prazosin showed greater improvement than hydroxyzine, which in turn was superior to placebo 1
- Nightmare reduction was associated with overall improvement in PTSD symptoms 1
A 2022 meta-analysis of pharmacological nightmare treatments found hydroxyzine had an effect size of g = 1.17, which is substantial, though lower than nabilone (g = 1.86) and higher than prazosin (g = 0.54). 4 This suggests hydroxyzine has clinically meaningful efficacy.
Mechanism of Action
Hydroxyzine is an H1-histamine antagonist that likely reduces nightmares through its sedating properties and anxiolytic effects, improving overall sleep architecture. 5, 4 The medication has established efficacy for generalized anxiety disorder, which commonly co-occurs with nightmare disorder. 5
Clinical Algorithm for Use
When to consider hydroxyzine for nightmares:
- PTSD-associated nightmares where prazosin is contraindicated (orthostatic hypotension risk, cardiovascular concerns) or not tolerated 1
- Idiopathic nightmares with comorbid anxiety, where the dual benefit of anxiety reduction and nightmare suppression is desirable 5, 1
- Patients who have failed or cannot access cognitive-behavioral therapies 2
Dosing considerations:
- The 2014 trial used hydroxyzine at therapeutic doses over 8 weeks 1
- Monitor for the primary side effect of drowsiness/sedation, which occurred more frequently than with other anxiolytics 3
Important Caveats
Hydroxyzine is not mentioned in AASM guidelines as a recommended treatment, placing it outside the standard treatment algorithm that prioritizes prazosin (Level A for PTSD nightmares) and cognitive-behavioral interventions. 2, 3 The medication falls into the category of agents with limited evidence compared to first-line options.
The evidence base consists primarily of one well-designed RCT 1 and inclusion in one meta-analysis 4, which is substantially less robust than the evidence for prazosin or imagery rehearsal therapy. 2, 3
Nightmare treatment improves multiple outcomes beyond nightmare frequency, including sleep quality, daytime fatigue, insomnia symptoms, and overall psychiatric symptoms, making treatment worthwhile even with second-line agents. 3, 1, 6
Practical Implementation
Start hydroxyzine when:
- Prazosin causes problematic orthostatic hypotension or dizziness 3
- The patient has significant comorbid generalized anxiety that would benefit from H1-antagonist treatment 5
- Access to specialized nightmare-focused cognitive behavioral therapy is limited 2
Expect moderate improvement in nightmare frequency and distress over 6-8 weeks of treatment, with concurrent improvement in PTSD or anxiety symptoms if present. 1